Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial
Marion Leboyer, Marianne Foiselle, Nicolas Tchitchek, Ryad Tamouza, Roberta Lorenzon, Jean‐Romain Richard, Raphaele Arrouasse, Philippe Le Corvoisier, Katia Le Dudal, Éric Vicaut, Pierre Ellul, Michèlle Rosenzwajg, David Klatzmann
Topics & Concepts
Depression (economics)Double blindInflammationPlaceboMedicineBipolar disorderInternal medicineImmune systemInterleukinImmunologyCytokineLithium (medication)PathologyAlternative medicineMacroeconomicsEconomicsBipolar Disorder and TreatmentTryptophan and brain disordersAdolescent and Pediatric Healthcare